Evidence map›Paper›PMID 37919375›Full record

ArticleBritish journal of cancer2023

Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.

Shivani Bailey, Marta Ferraresso, Luz Alonso-Crisostomo, Dawn Ward, Stephen Smith, James C Nicholson, Harpreet Saini, Anton J Enright, Cinzia G Scarpini, Nicholas Coleman and 1 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Shivani BaileyDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Marta FerraressoDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Luz Alonso-CrisostomoDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Dawn WardDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Stephen SmithDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.ORCID http://orcid.org/0000-0001-7744-3238
James C NicholsonDepartment of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
Harpreet SainiEMBL-European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Anton J EnrightDepartment of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Cinzia G Scarpini *Department of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK.
Nicholas Coleman *Department of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK. nc109@cam.a.cuk.
Matthew J Murray *Department of Pathology, University of Cambridge, Cambridge, CB2 1QP, UK. mjm16@cam.ac.uk.ORCID http://orcid.org/0000-0002-4480-1147
University of Cambridge · GBEuropean Bioinformatics Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37919375
PMCPMC10628269
OpenAlexW4388226589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.